Podcasts by HIV News & Views
"HIV News & Views" is an ongoing podcast series from TheBody.com/TheBodyPRO.com in which we talk with HIV doctors, researchers, advocates and others, to get their takes on important HIV news.
Further podcasts by TheBody.com
Podcast on the topic Wissenschaft
All episodes
Doctor Views: Ben Young, M.D., Ph.D. from 2021-09-09T06:57:59.670364
Dr. Young has been caring for people with HIV since 1994. Since that time, he's earned a reputation as an outspoken patient advocate, a personable clinician and a dedicated researcher. He talks to ...
Listen
Doctor Views: Kathleen Mulligan, Ph.D. from 2021-09-09T06:57:59.669695
Dr. Mulligan helped organize the first International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, the only medical conference focused entirely on body-shape changes in people with H...
Listen
Doctor Views: Bob Frascino, M.D. from 2021-09-09T06:57:59.669120
As an HIV health care provider and a person living with the virus, Dr. Frascino has a unique perspective. As someone who has struggled with lipoatrophy himself, he knows all too well what his patie...
Listen
Doctor Views: Minas Constantinides, M.D., FACS from 2021-09-09T06:57:59.668492
Dr. Constantinides is the director of facial plastic and reconstructive surgery at New York University School of Medicine. He's been doing reconstructive surgery on people with facial lipoatrophy s...
Listen
The Basics on Maraviroc from 2021-09-09T06:57:59.667757
It's been a year since the United States approved a new HIV medication, and four long years since we witnessed the birth of a whole new class of meds. But on Aug. 6, 2007, the U.S. Food and Drug Ad...
Listen
The Bottom Line on Isentress from 2021-09-09T06:57:59.666489
On Oct. 12, the U.S. Food and Drug Administration approved Isentress, the first member of a new class of meds called integrase inhibitors. Isentress is also known generically as raltegravir, and du...
Listen
How Isentress Works from 2021-09-09T06:57:59.665830
Dr. David Wohl briefly describes how Isentress differs from other meds. This is Part II of an update on Isentress.
Listen
News Analysis: U.S. Approval of Intelence (Etravirine) from 2021-09-09T06:57:59.665156
On Jan. 18, the U.S. Food and Drug Administration approved the first new non-nucleoside reverse transcriptase inhibitor in nearly a decade. It was known throughout much of its development as TMC125...
Listen
A Closer Look at the Revised U.S. HIV Treatment Guidelines (Part 1) from 2021-09-09T06:57:59.664458
On Dec. 1, 2007, the U.S. government released the first, and the biggest, part of its new HIV treatment guidelines. We asked Joel Gallant, M.D., M.P.H., to provide a summary of the changes. Dr. Gal...
Listen
A Closer Look at the New U.S. DHHS HIV Treatment Guidelines for Adults and Adolescents (Part 2) from 2021-09-09T06:57:59.663727
On Jan. 29, 2008, the U.S. government released the second part of its new HIV treatment guidelines. This second section contains antiretroviral recommendations. We asked Joel Gallant, M.D., M.P.H.,...
Listen
A New Way to Fight HIV: CCR5 Inhibitors from 2021-09-09T06:57:59.662657
The past year has brought so many new drug approvals that even some HIV experts are scratching their heads as they try to figure out how all of these meds work and how they can best be used to trea...
Listen
What's so Great About TMC114? from 2021-09-09T06:57:59.661991
TheBody.com interviewed Dr. Cal Cohen, one of the lead researchers who investigated TMC114 (darunavir, Prezista) in clinical trials, to get his take on some of the key questions surrounding this ne...
Listen
Update to the U.S. DHHS Antiretroviral Treatment Guidelines for Adults and Adolescents from 2021-09-09T06:57:59.660580
On Nov. 3, 2008, the U.S. government updated its Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. These guidelines were last updated on Jan. 29, 2008. We as...
Listen
Earlier HIV/AIDS Treatment Recommended in New Guidelines: Expert Summarizes from 2021-09-09T06:57:59.656879
Looking for an expert summary of the latest revisions to the official U.S. HIV treatment guidelines? Check out this exclusive interview with David Wohl, M.D., a prominent HIV physician/researcher a...
Listen
Innovative Widget Provides N.Y. Emergency Rooms With PEP Info from 2009-12-15T12:00
In New York, a new resource may help put an end to the confusion among emergency and general health care providers regarding HIV post-exposure prophylaxis (PEP) administration. The resource is a re...
Listen
Overweight People With HIV See Lower CD4 Gain While on HIV Medications, Study Suggests from 2009-11-19T12:00
Until the mid-1990s in the U.S., packing on a few extra pounds seemed like a good thing: It helped protect a person against the dangers of wasting and HIV's destructive effects on the immune system...
Listen
HIV/AIDS Activists Give Harsh Grades to Drug Companies from 2009-09-10T12:00
Abbott Laboratories: F. Hoffman-La Roche Ltd.: D. Boehringer Ingelheim: D+. If the nine major HIV drug companies were in school, most would probably be in detention, according to a new "report card...
Listen
HIV and Swine Flu (H1N1): An Update on Intersecting Pandemics from 2009-08-11T12:00
We had a short break from the panic over swine flu (H1N1). But as this year's flu season approaches in the U.S. and the rest of the Northern Hemisphere, fear appears to be ramping up again. Even ma...
Listen
What Does H1N1 (Swine) Flu Mean for People With HIV/AIDS? from 2009-04-29T12:00
As a swine flu virus appears to make its way across the world, so has misinformation and confusion about what the virus is and what sort of threat it poses, particularly for people with weakened im...
Listen
HIV Expert Answers Common HIV Questions in New Book from 2008-09-15T12:00
Joel Gallant, M.D., M.P.H., is not only a widely respected HIV clinician and researcher: He's also an online HIV expert, spending some of his free time answering questions about the virus. He's bee...
Listen